60
Participants
Start Date
August 16, 2011
Primary Completion Date
December 19, 2011
Study Completion Date
December 19, 2011
ondansetron
FDA approved drug used to treat nausea and vomiting
moxifloxacin
FDA approved antibiotic commonly used as a positive control in thorough QT studies
saline
USP saline IV solution used as placebo for ondansetron IV.
GSK Investigational Site, Austin
Lead Sponsor
GlaxoSmithKline
INDUSTRY